Reuters logo
BRIEF-Biophytis has FDA nod to initiate SARA-Interest Phase 2b interventional study of Sarconeos in sarcopenia
2017年10月30日 / 凌晨5点51分 / 24 天前

BRIEF-Biophytis has FDA nod to initiate SARA-Interest Phase 2b interventional study of Sarconeos in sarcopenia

Oct 30 (Reuters) - Biophytis Sa -

* Biophytis has FDA approval to initiate SARA-Interest Phase 2b interventional study of Sarconeos in Sarcopenia

* FDA’s approval will enable Biophytis to begin the SARA-Interest interventional study in five clinical centers in the United States Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below